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Boophone disticha L. Herb (Amaryllidaceae) is used in traditional medicine for treatment of painful wounds, headaches, skin disorders,
inflammatory conditions, rheumatic pains and anxiety. At least eight alkaloids have been characterized and reported in the literature. Of these
buphanidrine and buphanamine have affinity to the serotonin transporter (SERT). Alkaloids from other Amaryllidaceae species have also shown
affinity to SERT. In this study, an ethanol extract was prepared from dry bulbs. Through HPLC–UV separation five peaks were collected and
characterized by LC-MS and 1H NMR and led to the identification of crinine, buphanamine, buphanidrine, distichamine and buphanisine. The
activity of these compounds was tested in a binding assay using [3H]-citalopram as ligand and a functional SERT inhibition assay utilizing COS-7
cells expressing hSERT. The four active compounds, buphanamine, buphanidrine, buphanisine and distichamine, had IC50-values of 55 µM,
62 µM, 199 µM and 65 µM respectively, in the binding assay. The alkaloids also showed activity in the functional assay, buphanidrine and
distichamine being the most active with IC50-values of 513 µM and 646 µM, respectively.
© 2009 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Boophone disticha; Serotonin transporter; Traditional medicine1. Introduction
Boophone disticha (L.f.) Herb. (Syn=B. longepedicellata Pax)
iswidely distributed in SouthAfrica. It has been used in traditional
medicine for centuries. The Khoi/San people once used a poison
obtained from the bulb for their arrows. Decoctions and fresh
scales from the bulbs are used against burns, painful wounds, eye
conditions, pain, headaches, skin disorders, inflammatory condi-
tions, rheumatic pains and anxiety (Steenkamp, 2005). Bulb
decoctions are administered by the Zulu people, either orally or as
enemas, to hysterical adolescent female (Gordon, 1947). Bulbs are
used as a narcotic by Sotho and Xhosa (Watt and Breyer-
Brandwijk, 1962; Jacot Guillarmod, 1971; Hutchings et al., 1996).
The plant is also given to newly circumcised Sotho initiates,
producing a stupor (Jacot Guillarmod, 1971).Unspecified groups
use a weak decoction of the bulb scales which is commonly⁎ Corresponding author. Tel.: +45 35 306339; fax: +45 35 306041.
E-mail address: ankj@farma.ku.dk (A.K. Jäger).
0254-6299/$ - see front matter © 2009 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2009.02.173administered as a profound sedative to violent, psychotic patients
(Van Wyk and Gericke, 2000). Bulb infusions are reported to
cause hallucinations (Gelfand et al., 1985). Traditional healers and
patients in South Africa drink bulb infusions to induce
hallucinations for divinatory purposes, and also as a medicine to
treatmental diseases. However, many injuries result from the toxic
use of this plant (Sobiecki, 2002).
A number of biologically active alkaloids have been isolated
from the bulbs. Several alkaloids have been characterized and
reported. These include crinine, buphanidrine, buphanisine,
buphanamine, lycorine, powelline, distichamine and 3-O-
methylcrinamidine (Hauth and Stauffacher, 1961; Steenkamp,
2005). In a screening of plants used for anxiety and depression for
affinity to the serotonin transporter in rat brain, leaf extracts of
B. disticha had high affinity for the SSRI site (Nielsen et al.,
2004). A range of Amaryllidaceae alkaloids has earlier been
tested in a binding assay for affinity to the serotonin transporter
(SERT). Several of these tested compounds showed high to
moderate affinity for the transporter (Elgorashi et al., 2006). Ints reserved.
Fig. 1. Structures of (1) crinine, (2) buphanamine, (3) buphanidrine, (4) buphanisine and (5) distichamine.
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to have affinity to SERT (Sandager et al., 2005). This affinity was
attributed to the presence of a 1,3-dioxole moiety.
2. Materials and methods
2.1. Extraction
Boophone disticha bulbs were obtained from near Mpompo-
meni, KwaZulu-Natal (S 29°33.296′ E 30°11.468′, Alt 1085 m).
A voucher specimen has been deposited at the Bews Herbarium,
University ofKwaZulu-Natal, Pietermaritzburg (Stafford 53NU).
The bulbs were chopped and dried at 40 °C to constant weight and
ground to a powder. One-hundred fifty g ground dry bulbs were
extracted with 99.9% absolute ethanol (1×1500 ml, 1×1000 ml,
and 1×500 ml). During each extraction the plant material was
sonicated for 60 min. The extract was evaporated to dryness in
vacuo and the residue was dissolved in 150 ml ethyl acetate. The
solution was partitioned against 150 ml Milli-Q water (pH
adjusted to 3 with anhydrous acetic acid) in a separation funnel.Table 1
1H NMR (300 MHz, CDCl3) data of alkaloids isolated from Boophone disticha.
Position
naminea
δH multiplicity (J in Hz)
Bupha- Buphanidrinea Bupha
1 4.70 d (5.4) 6.58 d (9.2) 6.47 d
2 6.06 dddd (10.1; 5.5; 2.7; 1.9) 5.96 ddd (10.0; 5.2; 1.3) 6.08 dd
3 5.89 ddd (2.8; 4.4; 10.0) 3.82 ddd (1.9; 4.0; 5.5) 3.86 dd
4α 2.99 m 2.11 m 2.11 m
4β 2.31 m 1.60 dt (4.1; 13.5) 1.71 dt
4a 3.83 t (8.0) 3.31 dd (4.2; 13.5) 3.78 dd
6α 4.47 d (16.8) 4.25 d (17.4) 4.75 d
6β 4.16 d (16.8) 3.81 d (17.4) 4.13 d
7 6.56 s
10 6.60 s 6.56 s 6.86 s
11endo 2.02 m 2.15 ddd (4.4; 9.3; 12.6) 2.18 dd
11exo 2.15 m 1.92 ddd (6.0; 10.6; 12.2) 1,94 dd
12endo 3.08 ddd (?; 8.7; 13.3) 2.88 ddd (6.0; 9.2; 13.5) 2.91 dd
12exo 3.94 m 3.37 m 3.43 m
OCH2O 5.94 2xd (1.6) 5:86; 5.84 2xd (1.5) 5.97; 5
3-OMe 3,36 s 3.37 s
7-OMe 4.01 s 3,96 s
a: The NMR data are comparable to previously published data (Viladomat et al., 19The ethyl acetate phase was washed with 2×75 ml Milli-Q water
(pH 3). The pH was adjusted to 10 with NaOH and the aqueous
phase was partitioned against ethyl acetate (3×100ml). The ethyl
acetate phase was evaporated to dryness and freeze dried for 24 h,
yielding 240 mg residue.2.2. Isolation — preparative HPLC
Preparative HPLC was carried out on a Waters 1525 Binary
HPLC Pump, connected to a Waters 2996 Photodiode Array
Detector. A Luna-C18 column was used (250×21.20 mm×5 μm,
Phenomenex) eluted with a mixture of acetonitrile (MeCN) and
milli-Q water (MQ). The eluent composition was A: 100% MQ
and B: 100% MeCN. The column was eluted with a linear
gradient (A:B) from 100:0 (T0) to 0:100 (T30) to 0:100 (T35) at a
flow-rate of 10.0 ml/min. Samples (50 mg/ml, injection volume
450 µL) were filtered before each injection. Seven peaks were
collected and analyzed by 1H-NMR (CDCl3) on a Mercury
300MHzNMR instrument and LC-MS on an Agilent 6410 QQQnisinea Crininea Distichaminea
(10.1) 6.57 d (9.9)
(5.2; 10.1) 5.96 dd (5.4; 9.9) 5.43 d (1.6)
d (1.9; 5.5; 6.9) 4.34 dd (1.8; 5.6)
2.53 dd (6.6; 17.5)
(3.9; 13.5) 1.74 dt (4.1; 13.5) 2.42 ddd (1.6; 11.0; 17.5)
(3.8; 13.0) 3.40 dd (4.0; 13.6) 3.92 dd (6.2; 11.1)
(16.2) 4.39 d (16.8) 4.47 d (16.9)
(16.2) 3.77 d (16.8) 4,03 d (16.9)
6.47 s
6.84 s 7.79 s
d (4.4; 9.2; 13.0) 2.19 ddd (4.3; 9.1; 12.5) 2.35 ddd (4.2; 9.0; 12.8)
d (6.0; 10.6; 12.2) 1.93 ddd (6.1; 10.6; 12.3) 2.20 ddd (6.6; 10.5; 12.8)
d (6.0; 9.2; 13.2) 2.90 ddd (6.1; 9.0; 13,0) 2.90 ddd (6.6; 9.0; 12.9)
3.34 m 3.81 m
.95 2xd (1.3) 5.90; 5.88 2xd (1.4) 5.91; 5.89 2xd (1.4)
3.74 s
4.00 s
95; Sandager et al., 2005; Steenkamp, 2005).
Fig. 2. IC50 determinations for buphanamine (○), buphanidrine (□), buphanisine
(Δ) and distichamine (▿) in the binding assay.
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241 polarimeter.
2.3. [3H]-Citalopram binding assay
Themethod described by Plenge et al. (1990) andNielsen et al.
(2004) was used with modifications. Briefly, whole rat brains,
except cerebellum, were homogenized with an Ultra Turax
homogenizer in 1:10 (w/v) buffer (Tris base 5 mM; NaCl
150 mM; EDTA 20 mM; pH 7.5). The homogenate was
centrifuged at 14,000 g for 10 min and the homogenized tissue
pellet washed with the same buffer 1:10 (w/v). The supernatant
was discarded; the pellet was suspended in buffer (Tris base
5 mM; EDTA 5 mM; pH 7.5), left for 20 min at 0 °C and
centrifuged at 14,000 g for 10min. The supernatant was discarded
and the pellet was suspended in buffer (Tris base 50 mM; NaCl
120 mM; KCl 5 mM; pH 7.5) and centrifuged at 14,000 g for
10 min. The supernatant was discarded and the protein pellet
finally suspended in 1:10 (w/v) buffer (Tris base 500 mM; NaCl
1200mM; KCl 50mM; pH 7.5). The tissue homogenate was kept
at −80 °C until use.
The compounds were tested in a minimum of five concentra-
tions from 10 mg/ml (0.83 mg/ml in the assay) to 0.0003 mg/ml
(2.5.10−5 mg/ml in the assay). Twenty-five µl of each dilution
was mixed with 50 µl of [3H]-citalopram (4 nM, 0.67 nM in the
assay) and 225 µl of tissue suspension, respectively. The total
binding of [3H]-citalopram was determined with a solvent blank.
Paroxetin (120 µM, 10 µM in the assay) was used for the
determination of the non-specific binding. All samples were
incubated for 2 h at 25 °C and then filtered under vacuum using
Avantec GC50-25 mm glass fibre filters. The radioactivity on the
filters was determined by liquid scintillation using Ultimo Gold
XR as scintillation fluid. Specific binding was calculated as total
binding minus unspecific binding. All experiments were done in
triplicate.
2.4. Functional SERT inhibition assay
The method used is described in details elsewhere (Kristensen
et al., 2004). In short: COS-7 cells were cultured in Dulbecco's
modifiedEagle'smedium (DMEM)with 10% fetal bovine serum,
100 U/ml pencillin, 100 µg/ml streptomycin at 37 °C in a
humidified 5% CO2 environment. Cells were transfected with
hSERT constructs with TransIT transfection reagent (Mirus Inc.,
Madison, WI), following the protocol supplied by the manufac-
turer. Subsequently, cells were dispensed into poly-D-lysine
coated white 96-well plates at 50% confluence. Uptake inhibition
assay was performed 48 h after transfection when cells were
confluent. The media was removed and the cells were washed
twice with phosphate-buffered saline (in mM: NaCl, 137; KCl,
2.7; Na2HPO4, 4.3; and KH2PO4, 1.4, pH 7.3) containing 0.5mM
CaCl2 and 0.5 mM MgCl2 (PBSCM). After washing, cells were
incubated for 30min in PBSCMcontaining 50 nM [3H]-5-HTand
increasing concentrations of the alkaloids. Uptake was terminated
by washing twice with PBSCM. All washing steps were carried
out with an automatic plate washer (ELx50 Microplate Strip
Washer fromBiotek). The amount of accumulated [3H]-5-HTwasdetermined by solubilizing cells in scintillant (MicroScint-20)
followed by direct counting of plates in a Packard TopCounter.
Resulting counts were converted to % inhibition of a control well
that lacked alkaloids.3. Results and discussion
The Amaryllidaceae alkaloids were partially purified through
acidic-basic liquid partitioning. The LC-MS analysis of the
alkaloid-enriched fraction showed eight peaks in the UV
chromatogram (254 nm). By repeated preparative HPLC bupha-
namine, buphanidrine, buphanisine, crinine and distichamine were
isolated (Fig. 1). The compounds were identified by comparison
with previously publishedNMRdata. The 1HNMRdata of the five
compounds is listed in Table 1. However, with regards to dis-
tichamine not allNMRdatawere found in the literature. The optical
rotation for the compounds were: Buphanamine: a½ 28539 −43.1
(c 0.174mg/ml, CHCl3); buphanidrine: a½ 28539 −6.2 (c 0.256mg/ml,
CHCl3) Litt. value +4.2 (c 0.54, EtOH, 22 °C) (Viladomat et al.,
1995); Buphanisine: a½ 28539 −35.2 (c 0.125 mg/ml, CHCl3) Litt.
value −28 (c 0.6, EtOH, 22 °C) (Viladomat et al., 1995);
distichamine: a½ 28539 −41.6 (c 0.262 mg/ml, CHCl3).
Fig. 3. IC50 determinations for distichamine (▿) and buphanidrine (□) in the
functional SERT assay.
374 J.S. Neergaard et al. / South African Journal of Botany 75 (2009) 371–374The activity of the alkaloids observed in the SERT binding
assay (Fig. 2) was used to calculate IC50 values for the active
compounds using Grafit 5© (Erithacus Software Limited).
Buphanamine, buphanidrine and distichamine were the most
active with IC50 values of 55±4 µM (Ki=23 µM), 63±9 µM
(Ki = 26 µM) and 65±7 µM (Ki = 27 µM), respectively.
Buphanisine showed a relative lower potency giving an IC50
value of 199±25 µM (Ki=82 µM). Crinine showed only weak
activity in the SERTassay. This corresponds to earlier findings by
Elgorashi et al. (2006).
Only buphanidrine and distichamine were tested in the
functional SERT inhibition assay. Both buphanidrine and
distichamine showed activity in the functional assay (Fig. 3),
with IC50-values of 513±38 µM and 646±117 µM respectively.
The presence of the 1,3-dioxole moiety is suspected to be
responsible for the SERT affinity of these Amaryllidaceae
alkaloids (Sandager et al., 2005). It has been suggested that
some of these alkaloids could account for a dual effect in the
treatment of depression and Alzheimer's disease (Elgorashi et al.,
2006). However the crinine-type alkaloids which show affinity
for SERT has only weak acetylcholinesterase inhibitory effects
(Elgorashi et al., 2004). On the other hand, lycorine-type alkaloidshave demonstrated activity as acetylcholinesterase inhibitors, but
they showed no or only weak affinity for SERT (Elgorashi et al.,
2004, 2006).
The results from this study provide a rationale for the use of
B. disticha against anxiety and other central nervous system
diseases in traditional medicine and enhance our understanding
of the effects of this plant on the central nervous system.
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